In this issue of Clinical Watch, we highlight Dravet syndrome and suggest prior authorization criteria for a new anticonvulsant medication. Lastly, we review claims data for off-label use of anticonvulsants by age in children.
For more information about a topic, please contact Janelle Sheen, Karen Powell or Mary-Beth Plum. Be sure to watch for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.
Explore our Clinical Watch Newsletter
Learn MoreOther content in this Stream

Six -year contract will support state’s Medicaid and Children’s Health Insurance programs , employ ing more than 400 people in Topeka Selection comes as Medicaid enrollment is rising nationally...

In this issue of Clinical Watch, we discuss new antipsychotic medication formulations to tailor the management of schizophrenia and suggest prior authorization criteria for a new treatment for Cushing

Conduent can help states to swiftly and seamlessly implement their Electronic Visit Verification EVV Program. Learn how.

In this issue of Clinical Watch, we discuss nitrosamine impurities found in widely used medications and suggest prior authorization criteria for a new treatment for heavy menstrual bleeding

In this issue of Clinical Watch, we highlight the use of diabetes drugs in the treatment of heart failure and suggest prior authorization criteria for the first approved treatment of plexiform neurofi

In this issue of Clinical Watch, we highlight the NIH Panel recommendations regarding medications associated with COVID-19 treatment and suggest prior authorization criteria for the first approved tre

In this issue of Clinical Watch, we highlight aspects of Medicaid programs that are affected COVID-19 and suggest prior authorization criteria for a new lipid-lowering drug.

To successfully reopen the U.S. economy, public health agencies must perform extensive contact tracing to keep new cases of the virus from growing into a larger outbreak.

The need for timely, accurate information-sharing among key healthcare stakeholders is crucial to preventing the spread of COVID-19.